DWTX
Dogwood Therapeutics, Inc.
NASDAQ: DWTX · HEALTHCARE · BIOTECHNOLOGY
$1.43
+5.93% today
Updated 2026-04-30
Market cap
$46.09M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-7.13
Dividend yield
—
52W range
$1 – $10
Volume
0.1M
Dogwood Therapeutics, Inc. (DWTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-49.20%
ROA
-19.00%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | — | $-2.11M | — | — | — |
| 2019 | — | $-2.47M | — | — | — |
| 2020 | $0.00 | $-10.35M | — | — | — |
| 2021 | $0.00 | $-15.96M | — | — | — |
| 2022 | $0.00 | $-12.25M | — | — | — |
| 2023 | $0.00 | $-5.30M | — | — | — |
| 2024 | $0.00 | $-12.35M | — | — | — |
| 2025 | $0.00 | $-34.26M | — | — | — |